Insulet Corp (PODD)
174.43
+1.01
(+0.58%)
USD |
NASDAQ |
May 03, 16:00
174.46
+0.03
(+0.02%)
After-Hours: 20:00
Insulet Cash and Short Term Investments (Quarterly): 704.20M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 704.20M |
September 30, 2023 | 669.80M |
June 30, 2023 | 644.70M |
March 31, 2023 | 620.70M |
December 31, 2022 | 674.20M |
September 30, 2022 | 721.50M |
June 30, 2022 | 707.40M |
March 31, 2022 | 708.50M |
December 31, 2021 | 790.00M |
September 30, 2021 | 854.20M |
June 30, 2021 | 869.30M |
March 31, 2021 | 847.40M |
December 31, 2020 | 947.60M |
September 30, 2020 | 892.90M |
June 30, 2020 | 841.50M |
March 31, 2020 | 318.70M |
December 31, 2019 | 376.10M |
September 30, 2019 | 605.50M |
June 30, 2019 | 309.75M |
March 31, 2019 | 316.37M |
December 31, 2018 | 288.90M |
September 30, 2018 | 289.84M |
June 30, 2018 | 299.79M |
March 31, 2018 | 352.00M |
December 31, 2017 | 440.06M |
Date | Value |
---|---|
September 30, 2017 | 275.76M |
June 30, 2017 | 258.60M |
March 31, 2017 | 254.03M |
December 31, 2016 | 298.57M |
September 30, 2016 | 282.70M |
June 30, 2016 | 111.27M |
March 31, 2016 | 111.64M |
December 31, 2015 | 122.67M |
September 30, 2015 | 145.47M |
June 30, 2015 | 145.14M |
March 31, 2015 | 145.61M |
December 31, 2014 | 151.19M |
September 30, 2014 | 146.37M |
June 30, 2014 | 175.54M |
March 31, 2014 | 145.61M |
December 31, 2013 | 149.73M |
September 30, 2013 | 153.90M |
June 30, 2013 | 150.94M |
March 31, 2013 | 148.06M |
December 31, 2012 | 57.29M |
September 30, 2012 | 63.44M |
June 30, 2012 | 70.14M |
March 31, 2012 | 83.01M |
December 31, 2011 | 93.96M |
September 30, 2011 | 103.81M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
309.75M
Minimum
Jun 2019
947.60M
Maximum
Dec 2020
689.68M
Average
707.40M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
Abbott Laboratories | 7.279B |
Stryker Corp | 2.407B |
Tandem Diabetes Care Inc | 467.91M |
Becton Dickinson & Co | 3.175B |
ResMed Inc | 237.91M |